US Surgical acquires vascular repair technology:
This article was originally published in Clinica
US Surgical and EndoTex Interventional Systems have agreed to collaborate on the development of vascular repair technologies for aortic aneurysms and AV fistulas. The companies plan to begin clinical trials of EndoTex' stent graft for abdominal aortic aneurysm repair later this year. The agreement gives US Surgical the right to acquire the stent grafts and delivery systems, which can be used for iliac, femoral and thoracic aneurysm repair. Around 300,000 patients suffer an aneurysm every year in the US but only a small percentage of cases can be treated surgically.
You may also be interested in...
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.
At the OurCrowd Global Investor Summit, in Jerusalem, Israel, on 13 February, Medtech Insight met with start-up Sweetch, which has developed a personalized digital health coach for wellness and disease management.